TORONTO, Sept. 30, 2025 /PRNewswire/ -- Creyos, the digital platform reshaping brain health assessment in clinical care, is thrilled to announce…
The gold-standard dataset will power a new generation of AI tools to forecast Alzheimer's risk, track progression, and guide interventions…
- Clinical study conducted at the Dementia Research Centre, Nanyang Technological University, Singapore, involving Southeast Asian participants - Expert level accuracy,…
Leveraging MaxYield™ ECG to capture real-world exercise data in people living with neurological conditionsGenerating actionable insights into how cardiac responses…
Publication title: “Oral Blarcamesine Phase IIb/III Trial Confirms Identified Precision Medicine Patient Population – Significant Broad Clinical and Quality of…
CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma Patients Showed Extended Progression-Free Survival and…
ROCKAWAY, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today…
Based on previously reported positive Phase 1 results, Kynexis is advancing KYN-5356, a first-in-class KAT-II inhibitor, into a Phase 2…
BOSTON, Sept. 30, 2025 /PRNewswire/ -- BrainCo holds that the true value of technology lies in expanding the boundaries of…
MIDDLETON, Wis., Sept. 30, 2025 /PRNewswire/ -- Natus Medical Incorporated, the largest global pure-play neurodiagnostics company, today announced it has…